Page 16 - Pv News Today

John Mascarenhas, MD, and Joe Scandura, MD, PhD, close their discussion by highlighting what to look forward to in the future of polycythemia vera treatment.

The World Health Organization has said it’s the primary cause of cervical cancer, especially if an infection persists, though most do resolve on their own without symptoms.

Recent videos highlight the threat posed by FPV 'suicide drones' and one Russian countermeasure that is attempting to deal with them.

Prophecy Market Insights latest research report on the Vaccine Adjuvant Market provides a comprehensive analysis of the current market scenario, growth opportunities, challenges, and emerging trends. The report offers insights into the market's size and share, key market players, distribution channels, and consumer preferences. It also examines the impact of the COVID-19 pandemic on the market and provides a detailed analysis of the competitive landscape, including strategic alliances, merg...

The World Health Organization has said it’s the primary cause of cervical cancer, especially if an infection persists, though most do resolve on their own without symptoms.

Dr. Gerd examines the clinical choices involved in the management of PV, following the directives of NCCN guidelines.

In a study that did not achieve its recruitment goal, the patients who benefited most from the vaccine had previously responded to immunotherapy.

Key opinion leaders discuss data on the use of ruxolitinib in patients with polycythemia vera.

The US automaker has one of the most challenging jobs inside Stellan...

Risk factors for developing polycythemia vera (PV) are discussed by Aaron Gerds, MD, MS.